1. Home
  2. SCKT vs NLSP Comparison

SCKT vs NLSP Comparison

Compare SCKT & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCKT
  • NLSP
  • Stock Information
  • Founded
  • SCKT 1992
  • NLSP 2015
  • Country
  • SCKT United States
  • NLSP Switzerland
  • Employees
  • SCKT N/A
  • NLSP N/A
  • Industry
  • SCKT Computer Manufacturing
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • SCKT Technology
  • NLSP Health Care
  • Exchange
  • SCKT Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • SCKT 8.4M
  • NLSP 8.2M
  • IPO Year
  • SCKT 1995
  • NLSP 2021
  • Fundamental
  • Price
  • SCKT $1.16
  • NLSP $0.21
  • Analyst Decision
  • SCKT
  • NLSP Hold
  • Analyst Count
  • SCKT 0
  • NLSP 1
  • Target Price
  • SCKT N/A
  • NLSP N/A
  • AVG Volume (30 Days)
  • SCKT 6.9K
  • NLSP 26.8M
  • Earning Date
  • SCKT 07-31-2024
  • NLSP 07-30-2024
  • Dividend Yield
  • SCKT N/A
  • NLSP N/A
  • EPS Growth
  • SCKT N/A
  • NLSP N/A
  • EPS
  • SCKT N/A
  • NLSP N/A
  • Revenue
  • SCKT $17,699,212.00
  • NLSP N/A
  • Revenue This Year
  • SCKT $10.78
  • NLSP N/A
  • Revenue Next Year
  • SCKT $8.00
  • NLSP N/A
  • P/E Ratio
  • SCKT N/A
  • NLSP N/A
  • Revenue Growth
  • SCKT N/A
  • NLSP N/A
  • 52 Week Low
  • SCKT $0.90
  • NLSP $0.11
  • 52 Week High
  • SCKT $1.59
  • NLSP $1.21
  • Technical
  • Relative Strength Index (RSI)
  • SCKT 52.55
  • NLSP 56.71
  • Support Level
  • SCKT $1.06
  • NLSP $0.19
  • Resistance Level
  • SCKT $1.20
  • NLSP $0.22
  • Average True Range (ATR)
  • SCKT 0.05
  • NLSP 0.04
  • MACD
  • SCKT 0.01
  • NLSP 0.00
  • Stochastic Oscillator
  • SCKT 68.18
  • NLSP 16.67

About SCKT Socket Mobile Inc.

Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, out of which the majority of the revenue is generated from the United States.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: